Pfizer

In the US, the launch of vaccines hits problems with delays, an allergic case

In the US, the launch of vaccines hits problems with delays, an allergic case

Why Pfizer shares have reached their limit, according to one analyst

Alaskan has an allergic reaction after receiving the COVID-19 vaccine from Pfizer

Alaskan has an allergic reaction after receiving the COVID-19 vaccine from Pfizer

Asians reluctant to take the Covid-19 vaccine: a UK study

Covid-19 vaccine test volunteers report occasional hard side effects

Four companies are planning IPOs this week. Wish prices at the top of your range.

9 great takeaway menus from COVID-19 briefing by Michigan Governor Whitmer

Nanette Cocero, head of Pfizer’s vaccine program: “Our work is not over yet”